Insmed Statistics
NASDAQ: INSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
101.74-3.49 (-3.32%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Insmed by the numbers
Insmed has a market capitalization of $22.22 billion based on 218.38M shares outstanding. With trailing EPS of $-4.10, Insmed is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.0% below its 50-day average and 23.0% below its 200-day average.
Average daily trading volume is 2.56M shares, or about $260.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
INSM valuation vs. peer median
| Metric | INSM | Peer median | Difference |
|---|---|---|---|
| Market cap | $22.22B | $21.73B | +2% |
| Forward P/E | 130.9 | 17.9 | +630% |
| Avg. volume | 2.56M | 4.11M | -38% |
Peer median across 8 companies: UTHR, VTRS, ROIV, ASND, ZTS, ALNY, SMMT, BBIO.
Valuation
- Market cap
- $22.22B
- Forward P/E
- 130.87
- Price / sales (latest FY)
- 36.64
- EPS (TTM)
- $-4.10
- Shares outstanding
- 218.38M
Price and trading
- Previous close
- 105.23
- Open
- 103.90
- Day range
- 101.60 – 104.80
- 52-week range
- 90.39 – 212.75
- 52-week change
- -37.32%
- 50-day moving average
- 119.76
- 200-day moving average
- 132.14
- Beta
- —
- Volume
- 3.16M
- Average volume
- 2.56M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 22.22B
- Forward Pe
- 130.87
- Eps
- -4.10
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 212.75
- Week52 Low
- 90.39
- Avg Volume
- 2.56M
- Shares Outstanding
- 218.38M
- Ma50
- 119.76
- Ma200
- 132.14
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -52.18%
- Pct From52w Low
- 12.56%